![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TMEM171 mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1606157 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TMEM171 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1614025 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM171 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1614025 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of TMEM171 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | RGD:1606157 | 6480464 | Estradiol results in increased expression of TMEM171 mRNA | CTD | PMID:31614463 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1614025 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1614025 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1614025 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TMEM171 mRNA | CTD | PMID:21570461 | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | RGD:1614025 | 6480464 | tetrabromobisphenol A results in increased expression of TMEM171 mRNA | CTD | PMID:25172293 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1606157 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM171 mRNA | CTD | PMID:28628672 | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | affects abundance | ISO | RGD:1606157 | 6480464 | TMEM171 gene SNP affects the abundance of Uric Acid | CTD | PMID:23263486 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of TMEM171 mRNA | CTD | PMID:31881176 | acrylamide | affects expression | EXP | | 6480464 | Acrylamide affects the expression of TMEM171 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | RGD:1614025 | 6480464 | Acrylamide results in decreased expression of TMEM171 mRNA | CTD | PMID:30807115 | aflatoxin B1 | increases expression | ISO | RGD:1606157 | 6480464 | Aflatoxin B1 results in increased expression of TMEM171 mRNA | CTD | PMID:22100608 | aflatoxin B1 | decreases methylation | ISO | RGD:1606157 | 6480464 | Aflatoxin B1 results in decreased methylation of TMEM171 gene | CTD | PMID:27153756 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of TMEM171 mRNA | CTD | PMID:16483693 | antirheumatic drug | decreases expression | ISO | RGD:1606157 | 6480464 | Antirheumatic Agents results in decreased expression of TMEM171 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | RGD:1606157 | 6480464 | aristolochic acid I results in increased expression of TMEM171 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases methylation | ISO | RGD:1606157 | 6480464 | Benzo(a)pyrene results in decreased methylation of TMEM171 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1606157 | 6480464 | Benzo(a)pyrene results in increased expression of TMEM171 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | RGD:1606157 | 6480464 | Benzo(a)pyrene affects the methylation of TMEM171 promoter | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | ISO | RGD:1614025 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM171 mRNA | CTD | PMID:27858113 | benzo[b]fluoranthene | decreases expression | ISO | RGD:1614025 | 6480464 | benzo(b)fluoranthene results in decreased expression of TMEM171 mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | ISO | RGD:1614025 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM171 mRNA | CTD | PMID:27858113 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TMEM171 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1614025 | 6480464 | bisphenol A results in decreased expression of TMEM171 mRNA | CTD | PMID:25594700, PMID:32156529 | bisphenol F | multiple interactions | ISO | RGD:1606157 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM171 mRNA | CTD | PMID:28628672 | butanal | increases expression | ISO | RGD:1606157 | 6480464 | butyraldehyde results in increased expression of TMEM171 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | RGD:1606157 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMEM171 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1606157 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMEM171 mRNA | CTD | PMID:35301059 | calcium silicate | increases expression | ISO | RGD:1614025 | 6480464 | calcium silicate results in increased expression of TMEM171 mRNA | CTD | PMID:29279043 | carbon nanotube | increases expression | ISO | RGD:1614025 | 6480464 | Nanotubes, Carbon results in increased expression of TMEM171 mRNA | CTD | PMID:25554681 | chromium(6+) | affects expression | ISO | RGD:1606157 | 6480464 | chromium hexavalent ion affects the expression of TMEM171 mRNA | CTD | PMID:30690063 | chrysene | multiple interactions | ISO | RGD:1614025 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM171 mRNA | CTD | PMID:27858113 | CU-O LINKAGE | decreases expression | ISO | RGD:1606157 | 6480464 | cupric oxide results in decreased expression of TMEM171 mRNA | CTD | PMID:22077320 | dexamethasone | multiple interactions | ISO | RGD:1606157 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM171 mRNA | CTD | PMID:28628672 | dibenz[a,h]anthracene | decreases expression | ISO | RGD:1614025 | 6480464 | 1 more ... | CTD | PMID:26377693 | dichloroacetic acid | increases expression | ISO | RGD:1614025 | 6480464 | Dichloroacetic Acid results in increased expression of TMEM171 mRNA | CTD | PMID:28962523 | dioxygen | decreases expression | ISO | RGD:1606157 | 6480464 | Oxygen deficiency results in decreased expression of TMEM171 mRNA | CTD | PMID:26516004 | ethanol | multiple interactions | EXP | | 6480464 | [Fish Oils co-treated with Ethanol] results in increased expression of TMEM171 mRNA | CTD | PMID:17347304 | folic acid | multiple interactions | ISO | RGD:1614025 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM171 mRNA | CTD | PMID:22206623 | fonofos | increases methylation | ISO | RGD:1606157 | 6480464 | Fonofos results in increased methylation of TMEM171 promoter | CTD | PMID:22847954 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of TMEM171 mRNA | CTD | PMID:33387578 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of TMEM171 mRNA | CTD | PMID:21396975 | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMEM171 mRNA | CTD | PMID:22129741 | indometacin | multiple interactions | ISO | RGD:1606157 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM171 mRNA | CTD | PMID:28628672 | lipopolysaccharide | increases expression | ISO | RGD:1606157 | 6480464 | Lipopolysaccharides results in increased expression of TMEM171 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | RGD:1606157 | 6480464 | S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TMEM171 mRNA] | CTD | PMID:35811015 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMEM171 mRNA | CTD | PMID:22129741 | nickel sulfate | increases expression | ISO | RGD:1606157 | 6480464 | nickel sulfate results in increased expression of TMEM171 mRNA | CTD | PMID:22714537 | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of TMEM171 mRNA | CTD | PMID:33484710 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of TMEM171 mRNA | CTD | PMID:32680482 | parathion | increases methylation | ISO | RGD:1606157 | 6480464 | Parathion results in increased methylation of TMEM171 promoter | CTD | PMID:22847954 | PCB138 | multiple interactions | ISO | RGD:1614025 | 6480464 | [2 more ... | CTD | PMID:25510870 | pentanal | increases expression | ISO | RGD:1606157 | 6480464 | pentanal results in increased expression of TMEM171 mRNA | CTD | PMID:26079696 | perfluorononanoic acid | increases expression | ISO | RGD:1606157 | 6480464 | perfluoro-n-nonanoic acid results in increased expression of TMEM171 mRNA | CTD | PMID:32588087 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of TMEM171 mRNA | CTD | PMID:28511854 | pirinixic acid | multiple interactions | ISO | RGD:1614025 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TMEM171 mRNA | CTD | PMID:19710929 | potassium chromate | multiple interactions | ISO | RGD:1606157 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TMEM171 mRNA | CTD | PMID:22079256 | potassium chromate | increases expression | ISO | RGD:1606157 | 6480464 | potassium chromate(VI) results in increased expression of TMEM171 mRNA | CTD | PMID:22714537 | potassium chromate | decreases expression | ISO | RGD:1606157 | 6480464 | potassium chromate(VI) results in decreased expression of TMEM171 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of TMEM171 mRNA | CTD | PMID:19162173 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:1606157 | 6480464 | S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TMEM171 mRNA] | CTD | PMID:35811015 | silicon dioxide | increases expression | ISO | RGD:1606157 | 6480464 | Silicon Dioxide analog results in increased expression of TMEM171 mRNA | CTD | PMID:25895662 | sodium arsenite | increases expression | ISO | RGD:1606157 | 6480464 | sodium arsenite results in increased expression of TMEM171 mRNA | CTD | PMID:22714537 | succimer | multiple interactions | ISO | RGD:1614025 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM171 mRNA | CTD | PMID:21641980 | temozolomide | decreases expression | ISO | RGD:1606157 | 6480464 | Temozolomide results in decreased expression of TMEM171 mRNA | CTD | PMID:31758290 | terbufos | increases methylation | ISO | RGD:1606157 | 6480464 | terbufos results in increased methylation of TMEM171 promoter | CTD | PMID:22847954 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TMEM171 mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of TMEM171 mRNA | CTD | PMID:31150632 | tetraphene | multiple interactions | ISO | RGD:1614025 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM171 mRNA | CTD | PMID:27858113 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of TMEM171 mRNA | CTD | PMID:23411599 | titanium dioxide | increases expression | ISO | RGD:1614025 | 6480464 | titanium dioxide results in increased expression of TMEM171 mRNA | CTD | PMID:23557971 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of TMEM171 mRNA | CTD | PMID:30012374 | tributylstannane | decreases expression | EXP | | 6480464 | tributyltin results in decreased expression of TMEM171 mRNA | CTD | PMID:31129395 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of TMEM171 mRNA | CTD | PMID:33387578 | trovafloxacin | increases expression | ISO | RGD:1614025 | 6480464 | trovafloxacin results in increased expression of TMEM171 mRNA | CTD | PMID:35537566 | valproic acid | affects expression | ISO | RGD:1606157 | 6480464 | Valproic Acid affects the expression of TMEM171 mRNA | CTD | PMID:25979313 | zoledronic acid | increases expression | ISO | RGD:1606157 | 6480464 | zoledronic acid results in increased expression of TMEM171 mRNA | CTD | PMID:24714768 | |